Kumar Krishnan, MD
Gastroenterology · Boston, MANPI 1609085240
Payments from drug & device makers
Across 98 payments — averaging $607.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$20K
- Olympus Corporation Of The Americas$20K
- Olympus Corporation$12K
- Olympus Medical Systems Corporation$4K
- Gyrus ACMI, Inc.$2K
- Covidien LP$900
- plus $1K from 6 others
What the payments were for
- Consulting fees$43,14372%
- Speaking & faculty fees$11,68820%
- Travel & lodging$1,3482%
- Food & beverage$3,4036%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 21 | $20,183 |
| Olympus Corporation Of The Americas | 40 | $19,766 |
| Olympus Corporation | 8 | $11,633 |
| Olympus Medical Systems Corporation | 9 | $4,281 |
| Gyrus ACMI, Inc. | 2 | $1,545 |
| Covidien LP | 1 | $900 |
| Cook Medical LLC | 7 | $541 |
| Olympus America Inc. | 5 | $361 |
| Medtronic | 2 | $160 |
| Dilon Technologies, Inc. | 1 | $149 |
| AstraZeneca | 1 | $46 |
| Conmed Corporation | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL - THERAPIES$15,512
- Barrx$900
- GENERAL - BILIARY DEVICES$638
- EVIS EXERA III DUODENOVIDEOSCOPE$515
- EVIS EXERA III COLONOVIDEOSCOPE$513
- Hemospray$358
- AUTOTOME$213
- SPYGLASS$167
- HemoBlast Bellows$149
- EVIS EXERA lll COLONOVIDEOSCOPE$146
- OverStitch NXT Endoscopic Suturing System$139
- GI Genius$133
- GENERAL ENDOCHOICE$133
- VISIGLIDE$110
- ET General$103
How this compares
$59,580 in reported general payments places this provider in the 85th percentile of 579 gastroenterology providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CreonLipase/Protease/Amylase | 13 | $31,643 |
| Omeprazole | 42 | $871 |
| Esomeprazole Magnesium | 13 | $688 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 27 | $337 |
| Sucralfate | 11 | $297 |
| Pantoprazole Sodium | 19 | $150 |
| Ciprofloxacin Hcl | 27 | $113 |
| Nortriptyline Hcl | 11 | $73 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Boston
- Ramnik XavierBoston$14.3M
- Scott SnapperBoston$4.9M
- Jessica AllegrettiBoston$3.3M
- John LeungBoston$2.8M
- Michael DouganBoston$2M
- Raymond ChungBoston$1.4M
- Kathleen CoreyBoston$1.4M
- Joshua KorzenikBoston$1.2M
- Hiroyuki AiharaBoston$988K
- Carlo TraversoBoston$987K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.